Commonwealth Equity Services’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,138
Closed -$307K 4039
2023
Q3
$307K Sell
11,138
-4,125
-27% -$132K ﹤0.01% 3016
2023
Q2
$533K Sell
15,263
-6,270
-29% -$218K ﹤0.01% 2555
2023
Q1
$757 Buy
21,533
+1,116
+5% +$40.1K ﹤0.01% 2231
2022
Q4
$709K Sell
20,417
-357
-2% -$12.6K ﹤0.01% 2187
2022
Q3
$703K Sell
20,774
-712
-3% -$26.5K ﹤0.01% 2148
2022
Q2
$742K Buy
21,486
+272
+1% +$10.1K ﹤0.01% 2127
2022
Q1
$921K Buy
21,214
+375
+2% +$16.2K ﹤0.01% 2062
2021
Q4
$1.03M Buy
20,839
+1
+0% +$52 ﹤0.01% 1962
2021
Q3
$1.11M Buy
20,838
+1,280
+7% +$70.7K ﹤0.01% 1847
2021
Q2
$1.13M Buy
19,558
+2,458
+14% +$140K ﹤0.01% 1823
2021
Q1
$980K Buy
17,100
+13,709
+404% +$839K ﹤0.01% 1815
2020
Q4
$196K Buy
+3,391
New +$182K ﹤0.01% 2930

Other funds holding HEAL

Commonwealth Equity Services's HEAL Position: Q4 2023 in Review

Commonwealth Equity Services sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2023, closing a stake of 11,138 shares — an estimated $307K sold.

Commonwealth Equity Services first reported a position in HEAL in Q4 2020 and held it in 12 quarters. The position peaked at $1.13M in Q2 2021. 43 funds tracked by Wall St. Rank hold HEAL as of Q4 2023.

  • Commonwealth Equity Services reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,138 Global X Funds Global X HealthTech ETF shares in Q4 2023, an estimated $307K.
  • Commonwealth Equity Services first reported a position in Global X Funds Global X HealthTech ETF in Q4 2020 and held it in 12 quarters.
  • Commonwealth Equity Services's Global X Funds Global X HealthTech ETF position peaked at $1.13M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.